• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virol J . The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity

tetano

Editor, Senior Moderator
Virol J


. 2022 Mar 19;19(1):49.
doi: 10.1186/s12985-022-01783-5.
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity


Wenjing Gu[SUP] #[/SUP][SUP] 1 [/SUP], Hui Gan[SUP] #[/SUP][SUP] 2 [/SUP], Yu Ma[SUP] #[/SUP][SUP] 1 [/SUP], Lina Xu[SUP] 1 [/SUP], Zhangkai J Cheng[SUP] 2 [/SUP], Bizhou Li[SUP] 2 [/SUP], Xinxing Zhang[SUP] 1 [/SUP], Wujun Jiang[SUP] 1 [/SUP], Jinlv Sun[SUP] 3 [/SUP], Baoqing Sun[SUP] 4 [/SUP], Chuangli Hao[SUP] 5 [/SUP]



Affiliations

Abstract

The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has resulted in a global health emergency (COVID-19) because of its rapid spread and high mortality. Since the virus epidemic, many pathogenic mechanisms have been revealed, and virus-related vaccines have been successfully developed and applied in clinical practice. However, the pandemic is still developing, and new mutations are still emerging. Virus pathogenicity is closely related to the immune status of the host. As innate immunity is the body's first defense against viruses, understanding the inhibitory effect of SARS-CoV-2 on innate immunity is of great significance for determining the target of antiviral intervention. This review summarizes the molecular mechanism by which SARS-CoV-2 escapes the host immune system, including suppressing innate immune production and blocking adaptive immune priming. Here, on the one hand, we devoted ourselves to summarizing the combined action of innate immune cells, cytokines, and chemokines to fine-tune the outcome of SARS-CoV-2 infection and the related immunopathogenesis. On the other hand, we focused on the effects of the SARS-CoV-2 on innate immunity, including enhancing viral adhesion, increasing the rate of virus invasion, inhibiting the transcription and translation of immune-related mRNA, increasing cellular mRNA degradation, and inhibiting protein transmembrane transport. This review on the underlying mechanism should provide theoretical support for developing future molecular targeted drugs against SARS-CoV-2. Nevertheless, SARS-CoV-2 is a completely new virus, and people's understanding of it is in the process of rapid growth, and various new studies are also being carried out. Although we strive to make our review as inclusive as possible, there may still be incompleteness.

Keywords: Antiviral innate immunity; COVID-19; Molecular mechanism; PRR; SARS-CoV-2.
 
Back
Top Bottom